SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3076MJ, My question was more of a rhetorical query and I'm surprised you responjackie-12/19/2000
3075Jackie I have been investing for about 30 years. I do recall back in the 70'MJ-12/16/2000
3074Just curious: In the entire history of the stockmarket, has there ever been a djackie-12/16/2000
3073Antisense Drugs Topically Delivered to Skin Inhibit Gene Associated WithPsoriasibob zagorin-12/14/2000
3072Regarding shareholder rights-----while it will protect the management/the insideMJ-12/12/2000
3071Someone please tell me why they call this a shareholder rights plan. I see thatThe Band Leader-12/12/2000
3070Isis Pharmaceuticals Adopts Stockholder Rights Plan CARLSBAD, Calif., Dec. 8 /Pbob zagorin-12/8/2000
3069A private competitor using antisense for targeting. Potential patent dispute lotuck-12/7/2000
3068Cell Genesys CEO, Isis CMO Join Roth Capital Partners Analyst to Give CancerTherbob zagorin-12/6/2000
3067Wilder and Thread, Excellent overview of the current state of biologic treatmentuck-12/3/2000
3066Dr. Crooke talks about RNA and ISIP's RNA technologies in part two of the twtuck-11/20/2000
3065Isis Pharmaceuticals Provides Corporate Update in Webcast Presentation CARLSBADbob zagorin-11/17/2000
3064Here is the company overview website from their press release Nov. 17. The sitejuneau_boy-11/17/2000
3063news to me as well but i like the proof of concept.bob zagorin-11/14/2000
3062Not sure what this means. Have I forgotten about some kind of collaboration wittuck-11/14/2000
3061Isis Pharmaceuticals Provides Update of Phase I/II Clinical Trial of ISIS 3521Inbob zagorin-11/10/2000
3060I have equal posirions in both LGND and ISIP and consider both long term core bibob zagorin-11/9/2000
3059Anyone, how does ISIS 3521 results compare to Ligand's Targretin? Ligand maExtra Pale-11/8/2000
3058FDA Grants Isis Pharmaceuticals Fast Track Review StatusFor Isis 3521 in Non-Smabob zagorin-11/8/2000
3057this a.m. ISIS Pharm ISIP Roth Capital Buy $20bob zagorin-11/2/2000
3056Isis Pharmaceuticals Reports Record Low Quarterly Operating Loss in ThirdQuarterbob zagorin-11/2/2000
3055Other anti-sense devs... EpiGenesis Begins Human Trial of EPI-2010 Inhaled Antikeokalani'nui-10/30/2000
3054Isis Pharmaceuticals' TNF-alpha Inhibitor, ISIS 104838, Enters Phase I HumanSemiBull-10/29/2000
3053I wonder why they don't have a third group that is only using the Isis compoZencone-10/20/2000
3052Wednesday October 18, 7:58 am Eastern Time Press Release SOURCE: ISIS Pharmaceutbob zagorin-10/19/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News